Log in

NYSEARCA:XTiShares Exponential Technologies ETF Stock Price, Forecast & News

$42.58
+0.18 (+0.42 %)
(As of 05/29/2020 04:00 PM ET)
Add
Today's Range
$42.45
Now: $42.58
$43.12
50-Day Range
$37.41
MA: $39.79
$42.58
52-Week Range
$30.21
Now: $42.58
$45.33
Volume176,900 shs
Average Volume316,745 shs
Market Capitalization$2.31 billion
P/E RatioN/A
Dividend Yield1.56%
BetaN/A

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.4Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.01 out of 5 stars


Basic Details

Issuer iShares
Fund NameiShares Exponential Technologies ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:XT
Inception Date3/19/2015
Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkMorningstar Exponential Technologies Index
CategorySector
FocusTechnology
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$2.31 billion
Average Daily Volume$185,216.30
Discount/Premium0.00%

ETF Expenses

Management Fee0.47%
Other Expenses0.00%
Total Expenses0.47%
Fee Waiver0.00%
Net Expenses0.47%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerJane Street

Receive XT News and Ratings via Email

Sign-up to receive the latest news and ratings for XT and its competitors with MarketBeat's FREE daily newsletter.

Geographic Exposure of iShares Exponential Technologies ETF (NYSEARCA:XT)
Currency Exposure of iShares Exponential Technologies ETF (NYSEARCA:XT)
Sector Exposure of iShares Exponential Technologies ETF (NYSEARCA:XT)
Industry Exposure of iShares Exponential Technologies ETF (NYSEARCA:XT)

iShares Exponential Technologies ETF (NYSEARCA:XT) Frequently Asked Questions

How has iShares Exponential Technologies ETF's stock been impacted by COVID-19 (Coronavirus)?

iShares Exponential Technologies ETF's stock was trading at $37.06 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, XT stock has increased by 14.9% and is now trading at $42.58. View which stocks have been most impacted by Coronavirus.

Has iShares Exponential Technologies ETF been receiving favorable news coverage?

Media headlines about XT stock have been trending negative on Saturday, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. iShares Exponential Technologies ETF earned a coverage optimism score of -2.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutiShares Exponential Technologies ETF.

What is iShares Exponential Technologies ETF's stock symbol?

iShares Exponential Technologies ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XT."

How do I buy shares of iShares Exponential Technologies ETF?

Shares of XT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is iShares Exponential Technologies ETF's stock price today?

One share of XT stock can currently be purchased for approximately $42.58.

How big of a company is iShares Exponential Technologies ETF?

iShares Exponential Technologies ETF has a market capitalization of $2.31 billion.

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.